UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
(Check one):
 
x   Form 10-K o   Form 20-F o   Form 11-K o   Form 10-Q o   Form 10-D o   Form N-SAR o   Form N-CSR
 
             
   
For Period Ended:
 June 30, 2011
 
         
   
o    Transition Report on Form 10-K
   
             
   
o    Transition Report on Form 20-F
   
             
   
o    Transition Report on Form 11-K
   
             
   
o    Transition Report on Form 10-Q
   
             
   
o    Transition Report on Form N-SAR
   
             
   
For the Transition Period Ended:
     
 
 
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
 
 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
 
 
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
   
 
PART I — REGISTRANT INFORMATION
   
 
HEALTHIENT, INC.
 
Full Name of Registrant
   
 
 
 
Former Name if Applicable
   
 
15132 Park of Commerce Blvd.
 
Address of Principal Executive Office (Street and Number)
   
 
Jupiter, FL  33478
 
City, State and Zip Code
   
 
 
 
 
 
 
PART II — RULES 12b-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 
           
x
         
   
(a)
 
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
         
   
(b)
 
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
         
     
(c)
 
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
PART III — NARRATIVE
 
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
The Company is unable to file its Annual Report on Form 10-K for the period ended June 30, 2011 (the “Report”) by the prescribed date without unreasonable effort or expense because the Company has experienced delays in obtaining all necessary information for completing the required financial statements.  We expect to have the necessary information in possession with sufficient time to incorporate within the Report by the deadline of the extended time frame for filing.
 
 
(Attach extra Sheets if Needed)
 
PART IV — OTHER INFORMATION
 
 
(1)
 
Name and telephone number of person to contact in regard to this notification

/s/ Katherine West
 
561
 
935-6449
(Name)
 
(Area Code)
 
(Telephone Number)

(2)
 
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).
   
Yes  x      No  o
     
 
 
(3)
 
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
   
Yes  o      No  x
     
   
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 

 
 
 
 
 
 

Healthient, Inc.
(Name of Registrant as Specified in Charter)
 
 
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
             
Date
 
September 27, 2011
 
By
 
/s/ Katherine West
   
Date 
     
Title:  President
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Curative Biosciences (CE).
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Curative Biosciences (CE).